secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0000950170-24-000539
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq notice on Dec 28, 2023 that bid price compliance is regained.
- Previously warned on Nov 15, 2023 for closing below $1.00 for 30 consecutive days.
- Nasdaq has closed the matter; no further action required.
- Company's common stock (CADL) continues trading on Nasdaq Global Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024000539/0000950170-24-000539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017024000539/cadl-20231228.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-000539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer